Get started
Author

Gizachew Muluneh Amera

Observed name: Gizachew Muluneh
ORCID: 0000-0001-5079-5639
Observed ORCID: 0000-0001-5079-5639
OpenAlex ID: A5035028021
Targeting SARS-CoV-2: a systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2′-O-ribose methyltransferase
2020 · Rameez Jabeer Khan, Rajat Kumar Jha, et al. · Journal of Biomolecular Structure and Dynamics · 347
Insights into biological role of plant defense proteins: A review
2022 · Monika Jain, Gizachew Muluneh Amera, et al. · Biocatalysis and Agricultural Biotechnology · 66
A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods
2020 · Ekampreet Singh, Rameez Jabeer Khan, et al. · Journal of Genetic Engineering and Biotechnology · 59
PDF
Phytochemical Profile and Antimicrobial Effects of Different Medicinal Plant: Current Knowledge and Future Perspectives
2019 · Mulugeta Mulat, Fazlurrahman Khan, et al. · Current Traditional Medicine · 48
Identification of promising antiviral drug candidates against non-structural protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing study
2020 · Rameez Jabeer Khan, Rajat Kumar Jha, et al. · Journal of Biomolecular Structure and Dynamics · 32
Identification of promising molecules against MurD ligase from Acinetobacter baumannii: insights from comparative protein modelling, virtual screening, molecular dynamics simulations and MM/PBSA analysis
2020 · Rajat Kumar Jha, Rameez Jabeer Khan, et al. · Journal of Molecular Modeling · 29
Targeting Novel Coronavirus 2019: A Systematic Drug Repurposing Approach to Identify Promising Inhibitors Against 3C-like Proteinase and 2'-O-Ribose Methyltransferase
2020 · Rameez Jabeer Khan, Rajat Jha, et al. · ChemRxiv · 29
PDF
Structure based drug designing and discovery of promising lead molecules against UDP-N-acetylenolpyruvoylglucosamine reductase (MurB): A potential drug target in multi-drug resistant Acinetobacter baumannii
2020 · Gizachew Muluneh Amera, Rameez Jabeer Khan, et al. · Journal of Molecular Graphics and Modelling · 24
Screening of promising molecules against MurG as drug target in multi-drug-resistant-Acinetobacter baumannii - insights from comparative protein modeling, molecular docking and molecular dynamics simulation
2019 · Gizachew Muluneh Amera, Rameez Jabeer Khan, et al. · Journal of Biomolecular Structure and Dynamics · 21
Salmonella spp. and risk factors for the contamination of slaughtered cattle carcass from a slaughterhouse of Bahir Dar Town, Ethiopia
2014 · Gizachew Muluneh, Mulugeta Kibret · Asian Pacific Journal of Tropical Disease · 20
Structure based in-silico study on UDP-N-acetylmuramoyl-L-alanyl-D-glutamate-2,6-diaminopimelate ligase (MurE) from Acinetobacter baumannii as a drug target against nosocomial infections
2019 · Gizachew Muluneh Amera, Rameez Jabeer Khan, et al. · Informatics in Medicine Unlocked · 19
PDF
Computer aided ligand based screening for identification of promising molecules against enzymes involved in peptidoglycan biosynthetic pathway from Acinetobacter baumannii
2020 · Gizachew Muluneh Amera, Rameez Jabeer Khan, et al. · Microbial Pathogenesis · 17
Prioritization of Mur family drug targets against A. baumannii and identification of their homologous proteins through molecular phylogeny, primary sequence, and structural analysis
2020 · Gizachew Muluneh Amera, Rameez Jabeer Khan, et al. · Journal of Genetic Engineering and Biotechnology · 15
PDF
Identifying the natural compound Catechin from tropical mangrove plants as a potential lead candidate against 3CL pro from SARS-CoV-2: An integrated in silico approach
2021 · Rajat Kumar Jha, Rameez Jabeer Khan, et al. · Journal of Biomolecular Structure and Dynamics · 8
Identification of promising drug candidates against Non-Structural Protein 15 (NSP15) from SARS-CoV-2: an in silico assisted drug-repurposing studies
2020 · Rameez Jabeer Khan, Rajat Kumar Jha, et al. · ChemRxiv · 3
PDF
Ligand-Based Approaches for the Development of Drugs Against SARS-CoV-2
2021 · Ekampreet Singh, Rameez Jabeer Khan, et al. · Methods in pharmacology and toxicology · 2
From byte to bench to bedside: Structure-based drug design targeting the full-length human antigen R (HuR) protein using molecular docking and dynamics simulations
2026 · Gizachew Muluneh Amera, Giulia Canarutto, et al. · Chemical Physics Impact · 1
Delving into the Structural and Functional Characteristics of Mur Family Proteins in Acinetobacter baumannii strain AYE: A comprehensive Review
2024 · Gizachew Muluneh Amera, Giulia Canarutto, et al. · Preprints.org · 1
PDF
Computational Drug Repurposing for the Development of Drugs Against Coronaviruses
2021 · Ekampreet Singh, Rameez Jabeer Khan, et al. · Methods in pharmacology and toxicology · 1
Computational targeting of APE1–miRNA interactions in Cancer: Prioritization of candidate modulators
2026 · Gizachew Muluneh Amera, Giulia Canarutto, et al. · Bioorganic Chemistry
Exploiting selected Mur enzyme characteristics for antibacterial drug design
2026 · Gizachew Muluneh Amera, Giulia Canarutto, et al. · Journal of Microbiological Methods
A Comprehensive In Silico Study Towards Understanding the Inhibitory Mechanism of Lactoperoxidase by Dapsone and Propofol
2020 · Rameez Jabeer Khan, Rajat Kumar Jha, et al. · Current Computer - Aided Drug Design
Carcass Salmonella and Its Drug Resistance
2019 · Gizachew Muluneh Amera, Amit Kumar Singh · International Journal of Pathogen Research
Works count: 24
Citation count: 742
H-index: 13
I10-index: 13
Year
Topic
Type